Health Innovation Institute: Enormous potential in health data

Never have the opportunities to use data as a tool for securing the optimal communication about drugs’ potentials, price structures, and effects been better. But if citizens and the health system are to gain the maximal benefit from the products, they should be correctly positioned. And according to Claus Rehfeld from Health Innovation Institute, the life science industry must prove equal to the task.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Saniona starter studie med diabetestablet

Kombinationsbehandlingen tesomet fra det danske biotekselskab Saniona er blevet formuleret i én samlet tablet, hvilket skal gøre den mulige diabetesbehandling mere bekvem for patienterne, og man har nu startet et fase 1-studie med kandidaten i den nye formulering.

Latest Top picks in English

Related articles